Lessee, Operating Lease, Liability, to be Paid, Year Four of Insight Molecular Diagnostics Inc. from 30 Sep 2019 to 31 Dec 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Insight Molecular Diagnostics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 30 Sep 2019 to 31 Dec 2023.
Insight Molecular Diagnostics Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2023 was $695,000, a 23% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$695,000	-$204,000	-23%	31 Dec 2023	10-K	16 Apr 2024	2023	FY
Q3 2023	$695,000	-$204,000	-23%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$695,000			30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$695,000			31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$899,000			31 Dec 2022	10-K	12 Apr 2023	2022	FY
Q3 2022	$899,000			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q3 2019	$153,000			30 Sep 2019	10-Q	14 Nov 2019	2019	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.